AJANTPHARMPharmaceuticals
Ajanta Pharma Ltd — Balance Sheet
₹2805.10
-2.50%
Ajanta Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 12.49 Cr | 12.59 Cr | 12.67 Cr | 12.81 Cr | — |
| Share Issued | 12.49 Cr | 12.59 Cr | 12.67 Cr | 12.81 Cr | — |
| Total Debt | 47.42 Cr | 35.28 Cr | 35.63 Cr | 25.03 Cr | — |
| Tangible Book Value | 3.74K Cr | 3.55K Cr | 3.38K Cr | 3.26K Cr | — |
| Invested Capital | 3.79K Cr | 3.57K Cr | 3.39K Cr | 3.27K Cr | — |
| Working Capital | 1.85K Cr | 1.84K Cr | 1.69K Cr | 1.62K Cr | — |
| Net Tangible Assets | 3.74K Cr | 3.55K Cr | 3.38K Cr | 3.26K Cr | — |
| Capital Lease Obligations | 44.83 Cr | 33.79 Cr | 34.20 Cr | 23.12 Cr | — |
| Common Stock Equity | 3.79K Cr | 3.57K Cr | 3.39K Cr | 3.26K Cr | — |
| Total Capitalization | 3.79K Cr | 3.57K Cr | 3.39K Cr | 3.27K Cr | — |
| Total Equity Gross Minority Interest | 3.79K Cr | 3.57K Cr | 3.39K Cr | 3.26K Cr | — |
| Stockholders Equity | 3.79K Cr | 3.57K Cr | 3.39K Cr | 3.26K Cr | — |
| Other Equity Interest | 5.18 Cr | 5.65 Cr | 0.34 Cr | 0.30 Cr | — |
| Payables | 580.25 Cr | 558.04 Cr | 478.90 Cr | 406.41 Cr | — |
| Retained Earnings | 3.67K Cr | 3.31K Cr | 3.14K Cr | 2.72K Cr | — |
| Additional Paid In Capital | 4.31 Cr | 0.62 Cr | 0.44 Cr | 2.63 Cr | — |
| Capital Stock | 25.07 Cr | 25.27 Cr | 25.27 Cr | 17.17 Cr | — |
| Common Stock | 25.07 Cr | 25.27 Cr | 25.27 Cr | 17.17 Cr | — |
| Total Liabilities Net Minority Interest | 1.22K Cr | 1.07K Cr | 1.29K Cr | 791.23 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 228.56 Cr | 175.77 Cr | 151.75 Cr | 143.84 Cr | — |
| Other Non Current Liabilities | 2.00 Cr | 0.50 Cr | 2.67 Cr | -0.01 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 80.27 Cr | 39.54 Cr | 24.15 Cr | 19.32 Cr | — |
| Tradeand Other Payables Non Current | 1.05 Cr | 1.37 Cr | 1.01 Cr | 1.09 Cr | — |
| Non Current Deferred Revenue | 2.00 Cr | 2.34 Cr | 2.67 Cr | 3.00 Cr | — |
| Non Current Deferred Taxes Liabilities | 110.52 Cr | 108.50 Cr | 97.72 Cr | 101.87 Cr | — |
| Long Term Debt And Capital Lease Obligation | 34.72 Cr | 23.52 Cr | 26.20 Cr | 18.57 Cr | — |
| Long Term Capital Lease Obligation | 34.72 Cr | 23.52 Cr | 24.95 Cr | 16.93 Cr | — |
| Long Term Provisions | 80.27 Cr | 39.54 Cr | 24.15 Cr | 19.32 Cr | — |
| Current Liabilities | 996.10 Cr | 895.25 Cr | 1.14K Cr | 647.39 Cr | — |
| Other Current Liabilities | 91.12 Cr | -0.51 Cr | 23.15 Cr | 64.41 Cr | — |
| Current Deferred Taxes Liabilities | 40.53 Cr | 44.77 Cr | 33.07 Cr | 7.94 Cr | — |
| Current Debt And Capital Lease Obligation | 12.70 Cr | 11.76 Cr | 9.43 Cr | 6.46 Cr | — |
| Current Capital Lease Obligation | 10.11 Cr | 10.27 Cr | 9.25 Cr | 6.19 Cr | — |
| Current Debt | 2.59 Cr | 1.49 Cr | 0.18 Cr | 0.27 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 23.35 Cr | 17.76 Cr | 14.02 Cr | 10.81 Cr | — |
| Current Provisions | 263.18 Cr | 223.27 Cr | 186.43 Cr | 10.81 Cr | — |
| Other Payable | 124.95 Cr | 94.12 Cr | 55.31 Cr | 78.33 Cr | — |
| Dividends Payable | 1.10 Cr | 0.72 Cr | 0.82 Cr | 0.91 Cr | — |
| Total Tax Payable | 40.53 Cr | 44.77 Cr | 33.07 Cr | 7.94 Cr | — |
| Accounts Payable | 454.20 Cr | 463.20 Cr | 422.77 Cr | 327.17 Cr | — |
| Total Assets | 5.01K Cr | 4.64K Cr | 4.68K Cr | 4.06K Cr | — |
| Total Non Current Assets | 2.17K Cr | 1.91K Cr | 1.85K Cr | 1.79K Cr | — |
| Other Non Current Assets | -0.01 Cr | 9.44 Cr | 5.32 Cr | 6.54 Cr | — |
| Non Current Prepaid Assets | 5.54 Cr | 4.99 Cr | 11.01 Cr | 11.88 Cr | — |
| Non Current Deferred Taxes Assets | 186.43 Cr | 134.45 Cr | 96.77 Cr | 55.55 Cr | — |
| Investmentin Financial Assets | 28.44 Cr | 22.74 Cr | 29.00 Cr | 29.42 Cr | — |
| Available For Sale Securities | 3.20 Cr | 4.16 Cr | 3.90 Cr | 4.32 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 25.24 Cr | 18.58 Cr | 25.10 Cr | 25.10 Cr | — |
| Long Term Equity Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investmentsin Joint Venturesat Cost | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 46.52 Cr | 14.66 Cr | 7.75 Cr | 9.02 Cr | — |
| Other Intangible Assets | 46.52 Cr | 14.66 Cr | 7.75 Cr | 9.02 Cr | — |
| Net PPE | 1.90K Cr | 1.73K Cr | 1.70K Cr | 1.65K Cr | — |
| Accumulated Depreciation | -1.00K Cr | -881.04 Cr | -762.25 Cr | -683.42 Cr | — |
| Gross PPE | 2.90K Cr | 2.61K Cr | 2.46K Cr | 2.33K Cr | — |
| Construction In Progress | 184.94 Cr | 264.33 Cr | 209.47 Cr | 152.86 Cr | — |
| Other Properties | 1.72K Cr | 1.46K Cr | 1.49K Cr | 1.49K Cr | — |
| Machinery Furniture Equipment | 1.64K Cr | 1.47K Cr | 1.39K Cr | 1.33K Cr | — |
| Buildings And Improvements | 872.28 Cr | 664.93 Cr | 642.77 Cr | 630.34 Cr | — |
| Land And Improvements | 209.30 Cr | 211.43 Cr | 220.25 Cr | 220.09 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 2.84K Cr | 2.73K Cr | 2.83K Cr | 2.26K Cr | — |
| Other Current Assets | 123.30 Cr | 133.07 Cr | 91.61 Cr | 0.02 Cr | — |
| Hedging Assets Current | 0.00 | 12.48 Cr | 0.00 | 17.10 Cr | — |
| Assets Held For Sale Current | 13.33 Cr | 8.85 Cr | 8.82 Cr | 0.00 | — |
| Restricted Cash | 1.12 Cr | 1.28 Cr | 1.07 Cr | 5.42 Cr | — |
| Prepaid Assets | 78.39 Cr | 95.93 Cr | 58.63 Cr | 43.79 Cr | — |
| Inventory | 903.85 Cr | 828.36 Cr | 815.63 Cr | 791.07 Cr | — |
| Other Inventories | 49.77 Cr | 54.71 Cr | 51.71 Cr | 49.41 Cr | — |
| Finished Goods | 527.42 Cr | 486.05 Cr | 447.06 Cr | 455.11 Cr | — |
| Work In Process | 45.55 Cr | 54.35 Cr | 52.46 Cr | 46.50 Cr | — |
| Raw Materials | 281.11 Cr | 233.25 Cr | 264.40 Cr | 240.05 Cr | — |
| Other Receivables | 22.79 Cr | 23.34 Cr | 12.58 Cr | 15.09 Cr | — |
| Taxes Receivable | 26.98 Cr | 54.30 Cr | 40.27 Cr | 43.94 Cr | — |
| Accounts Receivable | 1.18K Cr | 1.25K Cr | 1.06K Cr | 1.02K Cr | — |
| Allowance For Doubtful Accounts Receivable | -5.89 Cr | -8.83 Cr | -11.04 Cr | -14.74 Cr | — |
| Gross Accounts Receivable | 1.19K Cr | 1.26K Cr | 1.07K Cr | 1.03K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 613.83 Cr | 459.54 Cr | 840.10 Cr | 328.22 Cr | — |
| Other Short Term Investments | 438.71 Cr | 330.05 Cr | 510.27 Cr | 121.86 Cr | — |
| Cash And Cash Equivalents | 175.12 Cr | 129.49 Cr | 329.83 Cr | 206.36 Cr | — |
| Cash Financial | 175.12 Cr | 129.49 Cr | 283.33 Cr | 206.36 Cr | — |
| Minority Interest | — | 0.00 | 0.00 | — | — |
| Long Term Debt | — | 0.00 | 1.25 Cr | 1.64 Cr | 1.60 Cr |
| Cash Equivalents | — | 0.00 | 46.50 Cr | 0.00 | — |
| Investment Properties | — | — | 0.00 | 8.41 Cr | 8.90 Cr |
| Treasury Shares Number | — | — | — | 0.42 Cr | 0.07 Cr |
| Trading Securities | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Ajanta Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.